The vector of anti-MAGEA3 T cell receptor (TCR) is constructed for the engineering of T cell to target Human MAGEA3. The T cells are genetically modified through transduction with a retroviral vector expressing MAGEA3-specific T cell receptor. And the vector product was designed for the treatment of Melanoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C244||Lenti-MAGE-A3 T cell receptor (R12C9) Viral Particle|
|TCR-L059Z||Murinized anti-MAGEA3 (aa243-258) T cell receptor, pCDTCR1|
|TCR-L246||Human anti-MAGE-A3 T cell receptor, pCDTCR1|
|TCR-C129Z||Human anti-MAGE-A3 T cell receptor (TCRVα38/Vβ2), pCDTCR1|
|VP-TCR-C251||Lenti-MAGE-A3 Murinized T cell receptor (6F9) Viral Particle|
|VP-TCR-C245||Lenti-MAGE-A3 T cell receptor (ESBI 648) Viral Particle|
|VP-TCR-C247||Lenti-MAGE-A3 T cell receptor (TCRVα3/Vβ28) Viral Particle|
|TCR-L245||Human anti-MAGE-A3 T cell receptor, pCDTCR1|
|TCR-L359||Human anti-MAGE-A3 T cell receptor (EB81-103), pCDTCR1|
|TCR-C123Z||Human anti-MAGE-A3 T cell receptor (A10), pCDTCR1|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved